Results 251 to 260 of about 12,480,959 (332)

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel   +8 more
wiley   +1 more source

Barriers for general practitioners in post-stroke follow-up within a fragmented healthcare system in Sweden - a focus group study. [PDF]

Eur J Gen Pract
Wolf M, Flink M, Carlsson AC, von Euler M, Hasselström J.   +4 more
europepmc   +1 more source

Primary Care Physician Organization Affiliations With Health Systems Between 2014 and 2019 Were Associated With Modest Improvements in Quality of Care. [PDF]

Med Care Res Rev
Timbie JW, DeYoreo M, Agniel D, Zhang S, Escarce JJ.   +4 more
europepmc   +1 more source

Nurses' perspectives on obtaining best possible medication histories in a virtual care setting: a qualitative study. [PDF]

BMC Health Serv Res
Zhang VZ, Pham M, Boscolo A, Armour K, Francis M.   +4 more
europepmc   +1 more source

Development to implementation to evaluation: step-by-step approach to embedding a clinical trial of a machine learning algorithm in the electronic health record. [PDF]

JAMIA Open
Morrison E, Overley J, Wurm K, Mock D, Bhavani SV.   +4 more
europepmc   +1 more source